Upregulated PCAT-1 predicts poor prognosis and reduced immune cell infiltration in head and neck squamous cell carcinoma through the miR-145-5p / FSCN-1 axis
Molecular Biology Reports,
Год журнала:
2025,
Номер
52(1)
Опубликована: Янв. 13, 2025
Язык: Английский
Dysregulated key long non-coding RNAs TP53TG1, RFPL1S, DLEU1, and HCG4 associated with epithelial-mesenchymal transition (EMT) in castration-resistant prostate cancer
Advances in Cancer Biology - Metastasis,
Год журнала:
2025,
Номер
unknown, С. 100132 - 100132
Опубликована: Янв. 1, 2025
Язык: Английский
Silencing of long non-coding RNAs MIR22HG, LNCTAM34A, and TP53TG1 triggers Cell survival/proliferation and inhibits apoptosis in women’s breast cancer
Advances in Cancer Biology - Metastasis,
Год журнала:
2025,
Номер
unknown, С. 100133 - 100133
Опубликована: Фев. 1, 2025
Язык: Английский
Non-Coding RNAs in Oral Cancer: Emerging Biomarkers and Therapeutic Frontier
Heliyon,
Год журнала:
2024,
Номер
10(21), С. e40096 - e40096
Опубликована: Ноя. 1, 2024
Around
the
world,
oral
cancer
(OC)
is
a
major
public
health
problem,
resulting
in
significant
number
of
deaths
each
year.
Early
detection
and
treatment
are
crucial
for
improving
patient
outcomes.
Recent
progress
DNA
sequencing
transcriptome
profiling
has
revealed
extensive
non-coding
RNAs
(ncRNAs)
transcription,
underscoring
their
regulatory
importance.
NcRNAs
influence
genomic
transcription
translation
molecular
signaling
pathways,
making
them
valuable
various
clinical
applications.
Combining
spatial
transcriptomics
(ST)
metabolomics
(SM)
with
single-cell
RNA
provides
deeper
insights
into
tumor
microenvironments,
enhancing
diagnostic
therapeutic
precision
OC.
Additionally,
exploration
salivary
biomarkers
offers
non-invasive
avenue.
This
article
explores
potential
ncRNAs
as
tools
Язык: Английский